Clinical Trials on Solid Neoplasm in Colombia
Total 4688 results
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Unresectable Solid NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Children's National Research InstituteRecruitingSolid TumorUnited States
-
Georgetown UniversityUnited States Department of DefenseCompleted
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Welichem Biotech Inc.Ozmosis Research Inc.Completed
-
INSYS Therapeutics IncCompletedSolid TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Childhood Solid NeoplasmUnited States
-
Georgetown UniversityPfizerUnknownAdvanced Solid Tumor MalignanciesUnited States
-
University of WashingtonNational Institute of Nursing Research (NINR)RecruitingMalignant Solid Neoplasm | Cancer | Parent-Child Relations | Parenting | Hematopoietic and Lymphoid System Neoplasm | SurvivorshipUnited States
-
NCIC Clinical Trials GroupNexstar PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
Cellectar, IncCompletedSolid TumorsUnited States
-
C17 CouncilCompletedRelapsed Malignant Solid TumorCanada
-
NCIC Clinical Trials GroupCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, Canada, Switzerland
-
Medstar Health Research InstituteBristol-Myers SquibbCompleted
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Childhood Solid NeoplasmUnited States
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Australia, Belgium, Denmark, Canada
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Belgium, Denmark, Canada, Australia
-
Chugai PharmaceuticalCompletedSolid TumorsUnited States, France, Netherlands
-
SanofiCompletedMalignant Solid Tumor - Malignant Nervous System NeoplasmUnited States, Canada
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
Novartis PharmaceuticalsCompletedSolid TumorsSpain, Canada, France, Denmark, Netherlands, Germany, Norway
-
Georgetown UniversityOregon Health and Science University; Tesaro, Inc.TerminatedHomologous Recombination Deficiency | Solid Tumor, AdultUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University HospitalActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupS*BIOCompletedLeukemia | Solid TumoursCanada
-
National Cancer Institute (NCI)CompletedChildhood Solid NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)CompletedCentral Nervous System Neoplasm | Solid NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Children's National Research InstituteActive, not recruiting
-
Bristol-Myers SquibbNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
PfizerKyowa Kirin Co., Ltd.TerminatedAdvanced/Metastatic Solid TumorsUnited States
-
Xilio Development, Inc.Active, not recruiting
-
Caris Science, Inc.Enrolling by invitation
-
Incyte CorporationCompletedSolid TumorsUnited States, Italy, United Kingdom, France, Belgium
-
Georgetown UniversityWyeth is now a wholly owned subsidiary of PfizerCompletedAdvanced Solid TumorsUnited States
-
Johns Hopkins UniversityBoston Scientific CorporationCompletedPancreatic Solid Lesions | Pancreatic MassUnited States
-
St. Jude Children's Research HospitalCompleted
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Ellipses PharmaRecruitingAdvanced Solid TumorUnited States, Spain, United Kingdom